Malaria disease Falciparum spp
After 60 years of research and the collaboration of numerous patients, two malaria vaccines have been approved by the WHO or EMA.
One key innovation is the use of saponin adjuvant systems in malaria vaccines. These unique compounds have been able to significantly enhance the immune response, and enabled the only vaccines approved by WHO against this deadly disease.
